お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
表紙:バイオインフォマティクスの世界市場:成長、動向、および予測(2021年~2026年)
市場調査レポート
商品コード
390860

バイオインフォマティクスの世界市場:成長、動向、および予測(2021年~2026年)

Bioinformatics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

出版日: | 発行: Mordor Intelligence Pvt Ltd | ページ情報: 英文 125 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=109.91円
バイオインフォマティクスの世界市場:成長、動向、および予測(2021年~2026年)
出版日: 2021年03月01日
発行: Mordor Intelligence Pvt Ltd
ページ情報: 英文 125 Pages
納期: 2-3営業日
担当者のコメント
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

当レポートは世界のバイオインフォマティクス市場について調査しており、市場機会や動向、成長および阻害要因、製品&サービス・用途・地域別の市場分析、競合情勢、主要企業のプロファイル等の情報を提供しています。

目次

第1章 イントロダクション

  • 調査成果
  • 調査の前提条件
  • 調査範囲

第2章 調査方法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場概況
  • 市場成長要因
    • 核酸およびタンパク質シーケンシング需要の増加
    • 政府および民間組織からの取り組みの増加
    • プロテオミクスおよびゲノミクスの成長の加速
    • 分子生物学および創薬に関する研究の増加
  • 市場阻害要因
    • 明確に定義された標準およびデータ統合のための一般的なデータ形式の欠如
    • データの複雑さの懸念およびユーザーフレンドリーなツールの欠如
  • ポーターのファイブフォース分析
    • 新規参入の脅威
    • バイヤー/消費者の交渉力
    • サプライヤーの交渉力
    • 代替製品の脅威
    • 業界内の競争

第5章 市場セグメント

  • 製品・サービス別
    • 知識管理ツール
    • バイオインフォマティクスプラットフォーム
    • バイオインフォマティクスサービス
  • 用途別
    • 微生物ゲノム
    • 遺伝子工学
    • 創薬
    • 個別化医療
    • オミクス
    • その他
  • 地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
    • 南米

第6章 競合情勢

  • 企業プロファイル
    • Illumina Inc.
    • Life Technologies (Thermo Fischer Scientific)
    • Qiagen NV
    • Agilent Technologies
    • PerkinElmer
    • ABM
    • Accelrys Inc.
    • Geneva Bioinformatics SA
    • Ontoforce
    • Data4Cure
    • Life Map Sciences (Biotime)

第7章 市場機会および今後の動向

目次
Product Code: 50460

The bioinformatics market is expected to register a CAGR of nearly 10.9% during the forecast period, with a revenue of approximately USD 9,665 million in 2020, and it is expected to reach 19,125 million by 2026.

During viral pandemics, sequencing and analyzing the data can be a valuable tool for the characterization and detection of viruses in the environment, animals, and human beings. Information related to transmission chains is critical for public health control and containment measures, while knowledge of virus variability can guide the development of vaccines and cheaper diagnostic methods.

For instance, in March 2020, the UK government has launched a new alliance called COVID-19 Genomics UK Consortium (COG-UK) to sequence the genomes of SARS-CoV-2 with whole-genome sequencing (WGS), the virus responsible for the current COVID-19 pandemic with an investment of EUR 20 million. The COVID-19 Genomics UK Consortium (COG-UK) is comprised of the NHS, Public Health Agencies, the Wellcome Sanger Institute, and several academic institutions. Thus, has likely to boost the market for bioinformatics over the forecast period.

The growth factors for the global bioinformatics market include the rising demand for nucleic acid and protein sequencing, rising initiatives from private and government organizations, accelerating growth of proteomics and genomics, and rising research on molecular biology and drug discovery. Owing to the above factors, the global bioinformatics market is expected to experience a rapid growth during the forecast period.

Bioinformatics is gaining importance, as a huge amounts of data created through techniques, like protein and nucleic acid sequencing, require data interpretation and management for medical purposes and future researches. Thus,rising demand is expected to drive the bioinformatics market during the forecast period.

Additionally, the introduction of technologically advanced bioinformatics software such as BALL, Bioclipse, RasMol, AUTODOCK and rising market usage of these tools for effective and accurate analysis of biomarkers discovery programs that assist in toxicity detection during the initial stage of the drug development process are expected to boost the industry growth over the upcoming years.

Furthermore, the demand for computational epigenetics, meta-analysis of microarray data, differentially expressed genes, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market. However, the lack of well-defined standards and common data formats for integration of data and data complexity concerns and lack of user-friendly tools is likely to hamper the market growth over forecast period.

Key Market Trends

Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period And Expected To Follow The Same Trend Over Forecast Period

Amid the current pandemic, personalized medicine is advancing at a breakneck speed. The Healthcare industry is focused on conducting personalized medicine and genomics research to better understand COVID-19 susceptibility, measure its impact, and discover potential therapies.

Personalized medicine has increased collaborative efforts between medical institutions, governments and researchers to swiftly develop effective treatments. For instance, in 2020, Summit Biolabs, Inc. and the Colorado Center for Personalized Medicine (CCPM) entered into a broad strategic partnership for conducting research, development, and commercialization of saliva liquid-biopsy tests for early cancer detection and diagnosis of COVID-19 and other viral contagions.

Developments in systems biology and pharmacogenomics have helped personalized medicine to transit from disease-centered and reductionism-based medical practice to system-based, integrative, and human-centered care.

Personalized medicine generates a strong impetus for scaling up the companion diagnostics tests to form personalized medicine for non-oncology cases. Rising prevalence of cancer, which boosts demand for personalized cancer therapeutics and diagnostics is also one of the key factors responsible for the growth of the market. As per data GLOBOCAN 2020, the global burden of cancer has increased to 19.3 million cases in 2020. Growing cancer-related spending is also amongst the drivers for segmental growth.

Europe Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

The outbreak of COVID-19 had an impact on the European bioinformatics market because healthcare services were significantly reduced due to social distancing measures taken by several governments across the globe. Government organizations in various countries, research institutes, and many biotech and pharmaceutical firms are focusing their resources on novel technologies for faster and accurate diagnosis of COVID-19. There is also immense research and work going on that are aimed at developing the vaccines, these R&D workflows utilize sequencing technologies extensively.

In March 2020, the UK government has launched a new alliance called COVID-19 Genomics UK Consortium (COG-UK) to sequence the genomes of SARS-CoV-2 with whole-genome sequencing (WGS), the virus responsible for the current COVID-19 pandemic with an investment of EUR 20 million. The COVID-19 Genomics UK Consortium (COG-UK) is comprised of the NHS, Public Health Agencies, the Wellcome Sanger Institute, and several academic institutions. This has positive impact on the regional maret growth.

A large number of healthcare investments in the European region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including United Kingdom, France and Italy are expected to propel the bioinformatics market in this region mainly.

Several companies are partnering and acquiring to strengthen their position in Bioinformatics market. For example, in 2019, Labfolder GmbH and cubuslab GmbH merged to develop platform for the integration of laboratory equipment and laboratory software control. These mergers are promoting the market growth. In addition, in 2019, TrialScope launched a clinical trials website for EMD Serono. Owing to these factors, the Europe bioinformatics market is expected to experience a boost during the forecast period

Competitive Landscape

Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing
    • 4.2.2 Increasing Initiatives from Governments and Private Organizations
    • 4.2.3 Accelerating Growth of Proteomics and Genomics
    • 4.2.4 Increasing Research on Molecular Biology and Drug Discovery
  • 4.3 Market Restraints
    • 4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data
    • 4.3.2 Data Complexity Concerns and Lack of User-friendly Tools
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

  • 5.1 By Product and Services
    • 5.1.1 Knowledge Management Tools
    • 5.1.2 Bioinformatics Platform
      • 5.1.2.1 Sequence Analysis Platform
      • 5.1.2.2 Sequence Alignment Platform
      • 5.1.2.3 Sequence Manipulation Platform
      • 5.1.2.4 Structural and Functional Analysis Platform
      • 5.1.2.5 Other Bioinformatics Platforms
    • 5.1.3 Bioinformatics Services
      • 5.1.3.1 Sequencing Services
      • 5.1.3.2 Database and Management Services
      • 5.1.3.3 Data Analysis
      • 5.1.3.4 Other Bioinformatics Services
  • 5.2 By Application
    • 5.2.1 Microbial Genome
    • 5.2.2 Gene Engineering
    • 5.2.3 Drug Development
    • 5.2.4 Omics
    • 5.2.5 Personalized Medicine
    • 5.2.6 Other Applications
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 3rd Millennium Inc.
    • 6.1.2 ABM
    • 6.1.3 Affymetrix
    • 6.1.4 Agilent Technologies
    • 6.1.5 BioWisdom Ltd
    • 6.1.6 Celera Corporation
    • 6.1.7 Dassault Systemes
    • 6.1.8 Data4Cure
    • 6.1.9 Geneva Bioinformatics SA
    • 6.1.10 Illumina Inc.
    • 6.1.11 Lineage Cell Therapeutics (BioTime Inc.)
    • 6.1.12 Ontoforce
    • 6.1.13 PerkinElmer
    • 6.1.14 Qiagen NV
    • 6.1.15 Rosetta Biosoftware
    • 6.1.16 Thermo Fischer Scientific (Life Technologies)

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.